MMP9 and breast carcinoma: Studies have shown that MMP9 is upregulated in breast cancer, where it correlates with poor patient survival outcomes, suggesting that its expression might facilitate tumor invasion and metastasis by remodeling the ECM to create pathways for cancer cell dissemination [30].